Cannabis industry enters 2021 with fresh markets, greater possibilities amid continuing challenges
Let’s face it: As terrible as 2020 was for numerous business sectors, it was surprisingly good for the cannabis industry in multiple ways.
Let’s face it: As terrible as 2020 was for numerous business sectors, it was surprisingly good for the cannabis industry in multiple ways.
Canadian licensed producers added a record 220,461 kilograms of marijuana to their inventories in October 2020, according to new data offering a statistical glimpse of the country’s first large-scale “croptober” – when most of the fall outdoor harvest comes in.
Canadian cannabis company Aphria on Thursday reported increased quarterly revenue for the quarter ended Nov. 30, with a net loss of 120.6 million Canadian dollars ($95.3 million).
A slim majority of eligible voters in Germany opposes legalizing recreational marijuana, according to a new poll.
Public health insurance reimbursements for cannabis in Germany have fallen for the second straight quarter.
Gröbenzell, Germany-based Ever Pharma is recalling all batches of its cannabis flower product CanPharma 20/1 after detecting contamination above acceptable levels, Marijuana Business Daily has learned.
The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed in that market need to think beyond simply offering a consistent supply of products.